Acacia Research Corporation has recently obtained an 11.8% stake in Sensyne Health

Acacia Research Corporation has recently obtained an eleven-point-eight per cent stake in the UK clinical artificial intelligence (AI) company, Sensyne Health, from the LF Equity Income fund.

Chief Executive Officer, Clifford Press, stated: “We recognise the extraordinary potential of Sensyne’s business model as conceived and implemented by Lord Drayson. As governance oriented investors, we are impressed by the constructive manner in which Sensyne has engaged with us as a major shareholder. We strongly support the continued development of a very talented management team for the next stage of the company’s growth.”